tiprankstipranks
Trending News
More News >
Envue Medical, Inc. (FEED)
:FEED

ENvue Medical Inc (FEED) Price & Analysis

Compare
376 Followers

FEED Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

FEED FAQ

What was Envue Medical, Inc.’s price range in the past 12 months?
Envue Medical, Inc. lowest stock price was $3.27 and its highest was $162.50 in the past 12 months.
    What is Envue Medical, Inc.’s market cap?
    Envue Medical, Inc.’s market cap is $3.69M.
      When is Envue Medical, Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Envue Medical, Inc.’s earnings last quarter?
      Currently, no data Available
      Is Envue Medical, Inc. overvalued?
      According to Wall Street analysts Envue Medical, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Envue Medical, Inc. pay dividends?
        Envue Medical, Inc. does not currently pay dividends.
        What is Envue Medical, Inc.’s EPS estimate?
        Envue Medical, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Envue Medical, Inc. have?
        Envue Medical, Inc. has 1,088,192 shares outstanding.
          What happened to Envue Medical, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Envue Medical, Inc.?
          Currently, no hedge funds are holding shares in FEED
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Envue Medical, Inc.

            NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

            Ownership Overview

            12.04%0.11%87.84%
            12.04%
            Insiders
            0.11%
            Mutual Funds
            ― Other Institutional Investors
            87.84% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks